Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteersFURLANUT, M; MONTANARI, G; PEROSA, A et al.International journal of clinical pharmacology research. 1985, Vol 5, Num 3, pp 165-170, issn 0251-1649Article

ADVERSE DRUG REACTIONS: A CONTINUING PROBLEMFELDMANN EG.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 585Article

GLC AND NMR ANALYSIS OF ISOMERIC IMPURITIES IN THE NEW ANTI-INFLAMMATORY AGENT BENOXAPROFEN.BROWNER SM; COCKERILL AF; MAIDMENT RJ et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 9; PP. 1305-1309; BIBL. 7 REF.Article

INTERNATIONAL SYMPOSIUM ON BENOXAPROFEN. PROCEEDINGS1980; J. RHEUMATOL.; CAN; DA. 1980; VOL. 7; SUPPL. 6; 143 P.; BIBL. DISSEM.Conference Paper

The phototoxic effect of benoxaprofen and its analogs on human erythrocytes and rat peritoneal mast cellsSIK, R. H; PASCHALL, C. S; CHIGNELL, C. F et al.Photochemistry and photobiology. 1983, Vol 38, Num 4, pp 411-415, issn 0031-8655Article

Analysis of solid-state carbon-13 NMR spectra of polymorphs (benoxaprofen and nabilone) and pseudopolymorphs (cefazolin)BYRN, S. R; GRAY, G; PFEIFFER, R. R et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 5, pp 565-568, issn 0022-3549Article

Activated α-alkyl-α-arylacetic acid enantiomers for stereoselective thin-layer chromatographic and high-performance liquid chromatographic determination of chiral aminesWEBER, H; SPAHN, H; MUTSCHLER, E et al.Journal of chromatography. 1984, Vol 307, Num 1, pp 145-153, issn 0021-9673Article

BENOXAPROFEN AND PAPILLARY NECROSISERWIN L; JONES JMB.1982; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1982; VOL. 285; NO 6343; PP. 694; BIBL. 3 REF.Article

PHOTOSENSIBILISIERUNG DURCH BENOXAPROFEN = LA PHOTOSENSIBILISATION PAR LE BENOXAPROFENWISKEMANN A.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 4; PP. 730-732; ABS. ENG; BIBL. 5 REF.Article

A COMPARATIVE TRIAL OF BENOXAPROFEN AND NAPROXENHIGHTON J; GRAHAME R.1978; RHEUMATOL. AND REHABILIT.; GBR; DA. 1978; VOL. 17; NO 4; PP. 259-264; BIBL. 8 REF.Article

PRELIMINARY STUDIES OF ABSORPTION AND EXCRETION OF BENOXAPROFEN IN MAN.SMITH GL; GOULBOURN RA; BURT RAP et al.1977; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1977; VOL. 4; NO 5; PP. 585-590; BIBL. 11 REF.Article

A DOUBLE-BLIND COMPARISON OF BENOXAPROFEN AND PLACEBO IN RHEUMATOID ARTHRITIS.LAMBERT JR; WRIGHT V.1977; CURR. MED. RES. OPINION; G.B.; DA. 1977; VOL. 5; NO 3; PP. 269-272; BIBL. 4 REF.Article

Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin: Studies by tandem mass spectrometryQIU, Y; BURLINGAME, A. L; BENET, L. Z et al.Drug metabolism and disposition. 1998, Vol 26, Num 3, pp 246-256, issn 0090-9556Article

Predicting the future from the lessons of the pastRAWLINS, M. D.International journal of pharmaceutical medicine. 1997, Vol 11, Num 1, pp 37-40, issn 1364-9027Article

LE BENOXAPROFENE PERMET-IL DE PREVENIR L'ASTHME A L'ACIDE ACETYLSALICYLIQUE.TONNEL AB; FOURNIER E; WALLAERT B et al.1982; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1982; VOL. 11; NO 49; PP. 3654-3655; BIBL. 3 REF.Article

EFFECTS OF THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG BENOXAPROFEN ON LEUCOCYTE MIGRATIONMEACOCK SCR; KITCHEN EA.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 6; PP. 366-370; BIBL. 12 REF.Article

DETERMINATION OF BENOXAPROFEN IN RAT FEED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY.MALLEN DNB; SHRUBSALL PR; MOORE RA et al.1978; J. CHROMATROGR.; NETHERL.; DA. 1978; VOL. 148; NO 2; PP. 514-516; BIBL. 4 REF.Article

Mechanisms of drug photosensitizationKOCHEVAR, I. E.Photochemistry and photobiology. 1987, Vol 45, Num 6, pp 891-895, issn 0031-8655Article

Fatal self-poisoning with benoxaprofenFRANCOURT, G. J; ADAMS, H; WALLS, J et al.Human toxicology. 1984, Vol 3, Num 6, pp 517-519, issn 0144-5952Article

EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON HUMAN LEUCOCYTESWILDFEUER A.1983; ZEITSCHRIFT FUER RHEUMATOLOGIE; ISSN 0340-1855; DEU; DA. 1983; VOL. 42; NO 1; PP. 16-20; ABS. GER; BIBL. 12 REF.Article

Spectroscopic studies of cutaneous photosensitizing agents. IV: The photolysis of benaxoprofen, an anti-inflammatory drug with phototoxic propertiesRESZKA, K; CHIGNELL, C. F.Photochemistry and photobiology. 1983, Vol 38, Num 3, pp 281-291, issn 0031-8655Article

ASSOCIATION BETWEEN STEVENS-JOHNSON SYNDROME AND BENOXAPROFENTAYLOR AEM; GOFF D; HINDSON TC et al.1981; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1981; NO 6274; PP. 1433; BIBL. 4 REF.Article

Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesisSIROIS, P; SALARI, H; BORGEAT, P et al.Inflammation. 1984, Vol 8, Num 4, pp 353-364, issn 0360-3997Article

BENOXAPROFEN: SIDE-EFFECT PROFILE IN 300 PATIENTSHALSEY JP; CARDOE N.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6326; PP. 1365-1368; BIBL. 22 REF.Article

EFFECTS OF FENOPROFEN AND BENOXAPROFEN ON HUMAN LYMPHOCYTES: INHIBITION OF TRITIATED THYMIDINE UPTAKE.PANUSH RS.1978; AGENTS AND ACTIONS; SWITZ.; DA. 1978; VOL. 8; NO 3; PP. 238-243; BIBL. 24 REF.Article